Wintest
6721
Liberta
4935
KODAMA CHEMICAL INDUSTRY
4222
GFA
8783
Good Life
2970
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 9.85%50.39B | 7.41%197.02B | 5.31%49.45B | 8.83%57.35B | 7.70%44.35B | 7.70%45.87B | 10.36%183.42B | 10.69%46.96B | 10.79%52.7B | 10.26%41.18B |
Cost of revenue | 21.41%3.43B | 14.80%13.87B | 10.35%3.61B | 7.75%4.25B | 21.68%3.18B | 25.66%2.83B | 20.50%12.08B | 14.19%3.28B | 35.04%3.95B | 13.82%2.61B |
Gross profit | 9.09%46.96B | 6.89%183.15B | 4.93%45.83B | 8.91%53.1B | 6.75%41.17B | 6.70%43.04B | 9.71%171.34B | 10.44%43.68B | 9.21%48.75B | 10.02%38.57B |
Operating expense | 14.27%31.06B | 7.09%123.06B | -1.38%31.45B | 15.97%36.33B | 9.47%28.1B | 4.43%27.18B | 7.89%114.91B | 11.23%31.89B | 5.63%31.33B | 7.62%25.67B |
Staff costs | ---- | 0.66%20.42B | ---- | ---- | ---- | ---- | 5.65%20.29B | ---- | ---- | ---- |
Selling and administrative expenses | ---- | 1.49%54.97B | ---- | ---- | ---- | ---- | 8.49%54.17B | ---- | ---- | ---- |
-Selling and marketing expense | ---- | -2.14%12.05B | ---- | ---- | ---- | ---- | 24.69%12.31B | ---- | ---- | ---- |
-General and administrative expense | ---- | 2.55%42.92B | ---- | ---- | ---- | ---- | 4.50%41.86B | ---- | ---- | ---- |
Depreciation and amortization | ---- | 53.11%3.84B | ---- | ---- | ---- | ---- | 5.42%2.51B | ---- | ---- | ---- |
-Depreciation | ---- | 70.29%3.49B | ---- | ---- | ---- | ---- | 3.69%2.05B | ---- | ---- | ---- |
-Amortization | ---- | -23.48%352M | ---- | ---- | ---- | ---- | 13.86%460M | ---- | ---- | ---- |
Other operating expenses | ---- | 15.49%43.83B | ---- | ---- | ---- | ---- | 8.43%37.95B | ---- | ---- | ---- |
Operating profit | 0.21%15.9B | 6.48%60.09B | 22.00%14.39B | -3.78%16.77B | 1.33%13.07B | 10.82%15.86B | 13.63%56.43B | 8.36%11.79B | 16.27%17.43B | 15.14%12.9B |
Net non-operating interest income (expenses) | -15.79%-22M | -4.35%-72M | 0.00%-17M | -5.88%-18M | 0.00%-18M | -11.76%-19M | -9.52%-69M | -6.25%-17M | -6.25%-17M | -28.57%-18M |
Non-operating interest income | 100.00%2M | -44.44%5M | -66.67%1M | 0.00%2M | -50.00%1M | -50.00%1M | -18.18%9M | 0.00%3M | -33.33%2M | -50.00%2M |
Non-operating interest expense | 20.00%24M | -1.28%77M | -10.00%18M | 5.26%20M | -5.00%19M | 5.26%20M | 5.41%78M | 5.26%20M | 0.00%19M | 11.11%20M |
Net investment income | -104.00%-4M | -10.78%91M | -107.06%-6M | 89.29%-3M | 0 | 3,433.33%100M | 3,300.00%102M | 1,316.67%85M | -1,300.00%-28M | 2,500.00%48M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 0.00%-41M | -555.43%-603M | -2,300.00%-552M | -400.00%-5M | 44.44%-5M | 30.51%-41M | -16.46%-92M | -1,050.00%-23M | 0.00%-1M | -9M |
Income from associates and other participating interests | ||||||||||
Special income (charges) | 1,425.00%53M | 836.36%721M | 8.82%-31M | 2,800.00%702M | -62.50%54M | 42.86%-4M | 119.69%77M | 75.18%-34M | 89.56%-26M | 3,700.00%144M |
Less:Other special charges | ---53M | -1,146.88%-670M | 416.67%31M | -2,364.52%-702M | ---- | ---- | -77.54%64M | -93.41%6M | -83.60%31M | 500.00%24M |
Less:Write off | --0 | 63.83%-51M | --0 | --0 | 67.26%-55M | 0.00%4M | -233.02%-141M | -39.13%28M | -108.33%-5M | ---168M |
Other non-operating income (expenses) | 40.91%62M | 1.98%206M | 3.13%33M | 25.00%70M | 20.41%59M | -32.31%44M | 26.25%202M | -38.46%32M | 69.70%56M | 16.67%49M |
Income before tax | 0.03%15.95B | 6.68%60.43B | 16.75%13.81B | 0.61%17.51B | 0.36%13.16B | 11.54%15.94B | 14.92%56.64B | 9.71%11.83B | 18.01%17.41B | 16.85%13.11B |
Income tax | 2.05%4.84B | -6.60%16.01B | -45.16%1.94B | 1.39%5.31B | -0.10%4.02B | 9.12%4.74B | 16.45%17.14B | 20.70%3.53B | 13.87%5.24B | 18.73%4.03B |
Net income | -0.84%11.11B | 12.44%44.42B | 43.11%11.87B | 0.27%12.2B | 0.57%9.14B | 12.60%11.2B | 14.27%39.5B | 5.63%8.3B | 19.88%12.17B | 16.03%9.09B |
Net income continuous operations | -0.83%11.11B | 12.45%44.42B | 43.13%11.87B | 0.28%12.2B | 0.56%9.14B | 12.60%11.2B | 14.27%39.5B | 5.62%8.29B | 19.88%12.17B | 16.04%9.09B |
Noncontrolling interests | 0 | 384.62%74M | 0 | 95.83%47M | 235.00%27M | 0 | -135.62%-26M | -235.71%-19M | -40.00%24M | -200.00%-20M |
Net income attributable to the company | -0.85%11.11B | 12.18%44.34B | 42.80%11.87B | 0.08%12.16B | 0.03%9.11B | 12.49%11.2B | 14.59%39.53B | 6.05%8.31B | 20.11%12.15B | 16.61%9.11B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -0.85%11.11B | 12.18%44.34B | 42.80%11.87B | 0.08%12.16B | 0.03%9.11B | 12.49%11.2B | 14.59%39.53B | 6.05%8.31B | 20.11%12.15B | 16.61%9.11B |
Gross dividend payment | ||||||||||
Basic earnings per share | 0.13%37.41 | 12.41%148.19 | 43.82%39.88 | 0.20%40.58 | 0.00%30.37 | 12.43%37.36 | 14.61%131.83 | 6.04%27.73 | 20.07%40.5 | 15.78%30.37 |
Diluted earnings per share | 0.13%37.41 | 12.41%148.19 | 43.85%39.88 | 0.20%40.58 | -0.04%30.3585 | 12.43%37.36 | 14.62%131.83 | 6.06%27.7232 | 20.07%40.5 | 15.78%30.37 |
Dividend per share | 0 | 60.00%104 | 34.15%55 | 0 | 104.17%49 | 0 | 12.07%65 | 13.89%41 | 0 | 9.09%24 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |